Health Italia S.p.A. (BIT:HI)
299.00
0.00 (0.00%)
Inactive · Last trade price on Mar 26, 2026
Health Italia Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 25, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 56 | 25 | 23 | 21 | 28 | 37 | |
Market Cap Growth | 141.13% | 12.40% | 9.01% | -25.70% | -24.15% | -50.88% |
Enterprise Value | 61 | 30 | 29 | 34 | 39 | 46 |
Last Close Price | 299.00 | 44.85 | 39.90 | 36.60 | 49.27 | 64.63 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 25, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 18.44 | 9.57 | 13.74 | 5.50 | 22.21 | 22.45 |
PS Ratio | 1.48 | 0.70 | 0.63 | 0.49 | 0.69 | 1.12 |
PB Ratio | 2.21 | 0.66 | 0.63 | 0.64 | 0.98 | 1.35 |
P/TBV Ratio | 2.62 | 0.73 | 0.70 | 0.77 | 1.24 | 1.74 |
P/FCF Ratio | - | 26.84 | 10.60 | - | - | 118.29 |
P/OCF Ratio | 44.21 | 8.31 | 10.60 | 9.62 | 34.50 | 118.29 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 25, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | 1.61 | 0.81 | 0.80 | 0.79 | 0.97 | 1.41 |
EV/EBITDA Ratio | 12.20 | 5.86 | 4.27 | 4.02 | 7.18 | 10.01 |
EV/EBIT Ratio | 14.56 | 6.52 | 5.24 | 4.93 | 9.70 | 15.45 |
EV/FCF Ratio | -68.36 | 31.26 | 13.56 | - | - | 148.98 |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 25, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.33 | 0.24 | 0.29 | 0.52 | 0.62 | 0.67 |
Debt / EBITDA Ratio | 1.67 | 1.62 | 1.53 | 2.02 | 3.22 | 3.95 |
Debt / FCF Ratio | - | 9.65 | 4.87 | - | - | 58.74 |
Net Debt / Equity Ratio | 0.19 | 0.16 | 0.18 | 0.37 | 0.37 | 0.39 |
Net Debt / EBITDA Ratio | 1.12 | 1.22 | 0.95 | 1.42 | 1.95 | 2.30 |
Net Debt / FCF Ratio | -5.47 | 6.51 | 3.02 | -6.92 | -81.59 | 34.20 |
Asset Turnover | 0.67 | 0.56 | 0.52 | 0.62 | 0.61 | 0.49 |
Inventory Turnover | - | - | - | 18.47 | 14.49 | 9.47 |
Quick Ratio | 2.12 | 2.09 | 1.97 | 1.19 | 1.87 | 1.68 |
Current Ratio | 2.47 | 3.18 | 2.59 | 1.25 | 1.98 | 1.90 |
Return on Equity (ROE) | 9.76% | 7.12% | 4.91% | 12.19% | 3.81% | 4.73% |
Return on Assets (ROA) | 4.61% | 4.32% | 4.96% | 6.20% | 3.80% | 2.82% |
Return on Invested Capital (ROIC) | 9.41% | 6.81% | 6.48% | 11.10% | 4.50% | 6.79% |
Return on Capital Employed (ROCE) | 12.20% | 9.30% | 11.70% | 17.10% | 8.50% | 6.30% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 25, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Earnings Yield | 5.50% | 10.45% | 7.28% | 18.20% | 4.50% | 4.46% |
FCF Yield | -1.60% | 3.73% | 9.43% | -8.24% | -0.47% | 0.84% |
Buyback Yield / Dilution | 0.15% | 0.00% | -0.81% | -0.58% | 1.37% | -0.05% |
Total Shareholder Return | 0.15% | 0.00% | -0.81% | -0.58% | 1.37% | -0.05% |